Affiliation:
1. College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
Abstract
Abstract
GRF(1–29)NH2 is degraded mainly by dipeptidyl peptidase IV (DPP IV) in plasma, resulting in inactivated GRF(3–29)NH2. To understand whether improving stability of GRF(1–29)NH2 in the plasma will result in enhanced stability in intestinal mucosal cells, stability of GRF(1–29)NH2 and [desNH2Tyr1,d-Ala2,Ala15]-GRF(1–29)NH2 in rat intestine brush-border membrane and homogenate was examined.
[desNH2Tyr1,d-Ala2,Ala15]-GRF(1–29)NH2, resistant to plasma DPP IV, was much more stable than GRF(1–29)NH2 in enterocytes. Gradient HPLC analysis, mass balance analysis and studies of inhibitor effects revealed that GRF(3–29)NH2 was the major metabolite of GRF(1–29)NH2 due to the action of DPP IV during incubation with brush-border membranes.
It is concluded that the design of peptide analogues to resist plasma enzymes dramatically increases stability in intestinal epithelium.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献